News & Media

Articles

Press Releases

Updates

Search

Articles

Neil Drug Discovery AI

ARTICLES 08.10.2023

Revolutionizing Drug Discovery with AI, Chemistry, and Biology

ARTICLES 08.01.2023

Revolutionizing Pharma: A Deep Dive into WuXi AppTec's BOLD Series with Totus Medicines

ARTICLES 07.17.2023

AI in Drug Discovery: Challenges and Opportunities

NCI ovarian tumor Totus

ARTICLES 04.18.2023

New PI3Kα Inhibitor TOS-358 Begins Clinical Trials for Solid Tumors

Small molecules

ARTICLES 03.02.2022

Small-Molecule Drugs: The Future of Medicine Beyond Complex Therapies

Neil Jason Jimmy

ARTICLES 12.09.2021

Developing Treatments for ‘Undruggable’ Diseases - Totus Featured in Forbes

ARTICLES 12.09.2021

Emerging from Stealth to Develop New PI3Kα Inhibitors for Cancer Treatment

Clinical trial 4

ARTICLES

New Cancer Drug TOS-358 Enters Phase I Trial with Accelerated Approval in Sight

Press Releases

PRESS RELEASES 12.15.2023

Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding

Maraganore John HS3

PRESS RELEASES 10.19.2023

John Maraganore, Ph.D. Joins Totus Medicines' Scientific Advisory Board

Neil undruggable

PRESS RELEASES 09.27.2023

Totus Makes a Mark at Future of R&D Week in Boston

Clinical trial 2

PRESS RELEASES 04.13.2023

Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors

PRESS RELEASES 04.12.2023

Totus Medicines Expands its Scientific Advisory Board with the Addition of Dr. Lewis Cantley, Dr. Hope Rugo, and Dr. Josep Tabernero

PRESS RELEASES 04.10.2023

Totus Medicines Announces Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting

PRESS RELEASES 01.04.2023

BioSpace Names Most Promising New Biopharma Companies to Watch in 2023 PR Newswire 01 04 2023

PRESS RELEASES 10.11.2022

Totus Medicines CEO to Present at Next-Generation Undruggable Conference

PRESS RELEASES 05.05.2022

Totus Medicines Announces Global Pharma Leader Tom Hughes as Board Chair & Creation of Scientific Advisory Board

PRESS RELEASES 03.31.2022

Totus Medicines Announces New San Francisco Bay Area Headquarters & Expanded Lab Space

PRESS RELEASES 03.24.2022

Totus Medicines Partners with Mila to Advance Drug Discovery Technologies in Mission to Treat the Untreatable

Ovid Trifan CMO

PRESS RELEASES 02.23.2022

Expert Clinical Developer Dr. Ovid Trifan and Veteran Drug Hunter Dr. Wei Chen Bring Decades of Complex Drug Development Experience to Totus Medicines

JPM hc conference graphic

PRESS RELEASES 01.11.2022

Totus Medicines to Present at 2022 J.P. Morgan HealthCare Conference

Daisy Chhokar CPO

PRESS RELEASES 01.06.2022

Totus Medicines Appoints Chief People Officer Daisy Chhokar and Chief Financial Officer Sam Singer to Senior Leadership Team

PRESS RELEASES 12.09.2021

Totus Medicines Emerges from Stealth with Revolutionary Drug Program Targeting PI3K-Alpha Oncogene

PRESS RELEASES 12.09.2021

Totus Medicines Emerges from Stealth with Revolutionary Drug Program Targeting PI3K-Alpha Oncogene

Updates

JP Morgan Healthcare Conference 2024

UPDATES 01.04.2024

Totus Medicines at J.P. Morgan Healthcare Conference

The Forefront of Innovative Drug Discovery and Development

UPDATES 10.04.2023

The Forefront of Innovative Drug Discovery and Development

UPDATES 08.14.2023

Totus Medicines Wins Stevie Award in the 2023 International Business Awards

UPDATES 01.04.2023

BioSpace Names Most Promising New Biopharma Companies to Watch in 2023

Platform Totus Meds Lab

A breakthrough cancer drug already, and more on the way.